Inhibitors of Aurora kinases for the treatment of cancer

被引：11
|
作者：
Fancelli, D [1 ]
Moll, J [1 ]
机构：
[1] BU Oncol, Nerviano Med Sci, I-20014 Nerviano, Italy
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2005年 / 15卷 / 09期
关键词：
Aurora kinase; cancer treatment; inhibitor; mitosis;
D O I：
10.1517/13543776.15.9.1169
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Aurora protein kinases are key players in different steps during mitosis and their activity is required for correct cell division. The inhibition of Aurora kinases is regarded as a promising approach for the development of novel anticancer agents. In the last few years several templates for ATP-competitive kinase inhibition have been successfully developed towards the inhibition of Aurora kinases, and the first compounds have recently entered clinical studies. This review summarises the patent literature up until March 2005 and the characteristics of the low molecular weight Aurora inhibitors described so far.
引用
收藏
页码：1169 / 1182
页数：14
相关论文
共 50 条
  • [1] Targeting Aurora Kinases in Cancer Treatment
    Kelly, Kevin R.
    Ecsedy, Jeffrey
    Mahalingam, Devalingam
    Nawrocki, Steffan T.
    Padmanabhan, Swaminathan
    Giles, Francis J.
    Carew, Jennifer S.
    CURRENT DRUG TARGETS, 2011, 12 (14) : 2067 - 2078
  • [2] Targeting aurora kinases for the treatment of prostate cancer
    Lee, Edmund Chun Yu
    Frolov, Anna
    Li, Rile
    Ayala, Gustavo
    Greenberg, Norman M.
    CANCER RESEARCH, 2006, 66 (10) : 4996 - 5002
  • [3] Small Molecule Aurora Kinases Inhibitors
    Garuti, Laura
    Roberti, Marinella
    Bottegoni, Giovanni
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (16) : 1949 - 1963
  • [4] Aurora kinases in ovarian cancer
    Perez-Fidalgo, J. Alejandro
    Gambardella, Valentina
    Pineda, Begona
    Burgues, Octavio
    Pinero, Oscar
    Cervantes, Andres
    ESMO OPEN, 2020, 5 (05)
  • [5] Aurora Kinase Inhibitors in Breast Cancer Treatment
    Opyrchal, Mateusz
    Sangameswaran, Kothai Divya Guruswamy
    Khoury, Thaer
    Boland, Patrick
    Galanis, Evanthia
    Haddad, Tufia C.
    D'Assoro, Antonino B.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (12) : 14 - 18
  • [6] Progress in the development of selective inhibitors of Aurora kinases
    Mortlock, A
    Keen, NJ
    Jung, FH
    Heron, NM
    Foote, KM
    Wilkinson, R
    Green, S
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 199 - 213
  • [7] Aurora kinases in head and neck cancer
    Mehra, Ranee
    Serebriiskii, Ilya G.
    Burtness, Barbara
    Astsaturov, Igor
    Golemis, Erica A.
    LANCET ONCOLOGY, 2013, 14 (10): : E425 - E435
  • [8] Targeting Aurora kinases in ovarian cancer
    Fu, SQ
    Hu, W
    Kavanagh, JJ
    Bast, RC
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (01) : 77 - 85
  • [9] Aurora kinases as targets for cancer therapy
    Mountzios, Giannis
    Terpos, Evangelos
    Dimopoulos, Meletios-Athanassios
    CANCER TREATMENT REVIEWS, 2008, 34 (02) : 175 - 182
  • [10] Aurora kinases in chromosomal instability and cancer
    不详
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 121 : 26 - 27
12345